Rapid detection of Ebolavirus using isothermal recombinase‐aided amplification
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29744 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Arianna Ceruti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Animal Hygiene and Veterinary Public Health, Leipzig University, Leipzig, Germany. Hauptthemen laut MEDLINE: Ebolavirus, Hemorrhagic Fever, Ebola, Nucleic Acid Amplification Techniques, Sensitivity and Specificity. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership (EDCTP), European Union.
Abstract (Originalsprache)
Ebolavirus disease (EVD) is an often‐lethal disease caused by the genus Ebolavirus (EBOV). Although vaccines are being developed and recently used, outbreak control still relies on a combination of various factors, including rapid identification of EVD cases. This allows rapid patient isolation and control measure implementation. Ebolavirus diagnosis is performed in treatment centers or reference laboratories, which usually takes a few hours to days to confirm the outbreak or deliver a clear result. A fast and field‐deployable molecular detection method, such as the isothermal amplification recombinase‐aided amplification (RAA), could significantly reduce sample‐to‐result time. In this study, a RT‐RAA assay was evaluated for EBOV detection. Various primer and probe combinations were screened; analytical sensitivity and cross‐specificity were tested. A total of 40 archived samples from the 2014 to 2016 Ebola outbreak in West Africa were tested with both the reference method real‐time RT‐PCR and the established RT‐RAA assay. The assay could detect down to 22.6 molecular copies per microliter. No other pathogens were detected with the Ebolavirus RT‐RAA assay. Testing 40 samples yield clinical sensitivity and specificity of 100% each. This rapid isothermal RT‐RAA assay can replace the previous RT‐RPA and continue to offer rapid EBOV diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Animal Hygiene and Veterinary Public Health, Leipzig University, Leipzig, Germany.
- Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.
- Department of Virology at the Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
- Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
- Institute of Microbiology and Virology, Medizinische Hochschule Brandenburg Theodor Fontane, Neuruppin, Germany.
ORCID-Profile: Arianna Ceruti, Martin Faye, Moussa M Diagne
Förderung
- European and Developing Countries Clinical Trials Partnership (EDCTP)
- European Union
Zitieren
APA
Ceruti, A., Faye, M., Diagne, M. M., Kobialka, R. M., Makiala-Mandanda, S., Faye, O., Faye, O., El Wahed, A. A., & Weidmann, M. (2024). Rapid detection of Ebolavirus using isothermal recombinase‐aided amplification. Journal of Medical Virology. https://doi.org/10.1002/jmv.29744
Vancouver
Ceruti A, Faye M, Diagne MM, Kobialka RM, Makiala-Mandanda S, Faye O, et al. Rapid detection of Ebolavirus using isothermal recombinase‐aided amplification. Journal of Medical Virology. 2024. doi:10.1002/jmv.29744
BibTeX
@article{Ceruti2024,
author = {Ceruti, Arianna and Faye, Martin and Diagne, Moussa M and Kobialka, Rea M and Makiala-Mandanda, Sheila and Faye, Ousmane and Faye, Oumar and El Wahed, Ahmed A and Weidmann, Manfred},
title = {Rapid detection of Ebolavirus using isothermal recombinase‐aided amplification},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29744}
}
EUVIMED